GLP-1 receptor agonist use does not increase risk of respiratory complications post-endoscopy.

IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Endoscopy International Open Pub Date : 2025-01-13 eCollection Date: 2025-01-01 DOI:10.1055/a-2487-2937
Jena Velji-Ibrahim, Piyush Nathani, Harsh K Patel, Prateek Sharma
{"title":"GLP-1 receptor agonist use does not increase risk of respiratory complications post-endoscopy.","authors":"Jena Velji-Ibrahim, Piyush Nathani, Harsh K Patel, Prateek Sharma","doi":"10.1055/a-2487-2937","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and study aims: </strong>Data on respiratory complications associated with GLP-1 receptor agonist (GLP-1 RA) use before endoscopic procedures are limited.</p><p><strong>Patients and methods: </strong>We conducted a retrospective cohort study using TriNetX in adults with diabetes or obesity on GLP-1 RAs within 3 months of endoscopy, comparing them with non-GLP-1 RA users. Propensity score matching and Cox proportional hazards models were used to assess outcomes.</p><p><strong>Results: </strong>Among 46,948 patients, no significant differences in post-endoscopy aspiration pneumonitis (hazard ratio [HR] 0.92, 95% confidence interval [CI] 0.54-1.56) or pneumonia (HR 1.01, 95% CI 0.83-1.24) were found between groups.</p><p><strong>Conclusions: </strong>GLP-1 RA use before endoscopy does not increase respiratory complications, supporting continued preoperative medication use.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a24872937"},"PeriodicalIF":2.3000,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11827728/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endoscopy International Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-2487-2937","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and study aims: Data on respiratory complications associated with GLP-1 receptor agonist (GLP-1 RA) use before endoscopic procedures are limited.

Patients and methods: We conducted a retrospective cohort study using TriNetX in adults with diabetes or obesity on GLP-1 RAs within 3 months of endoscopy, comparing them with non-GLP-1 RA users. Propensity score matching and Cox proportional hazards models were used to assess outcomes.

Results: Among 46,948 patients, no significant differences in post-endoscopy aspiration pneumonitis (hazard ratio [HR] 0.92, 95% confidence interval [CI] 0.54-1.56) or pneumonia (HR 1.01, 95% CI 0.83-1.24) were found between groups.

Conclusions: GLP-1 RA use before endoscopy does not increase respiratory complications, supporting continued preoperative medication use.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
GLP-1受体激动剂的使用不会增加内镜检查后呼吸道并发症的风险。
背景和研究目的:在内镜手术前使用GLP-1受体激动剂(GLP-1 RA)相关的呼吸系统并发症的数据有限。患者和方法:我们进行了一项回顾性队列研究,在内镜检查后3个月内使用TriNetX治疗GLP-1 RAs的成人糖尿病或肥胖患者,并将其与非GLP-1 RA使用者进行比较。倾向评分匹配和Cox比例风险模型用于评估结果。结果:46,948例患者中,内镜术后吸入性肺炎(风险比[HR] 0.92, 95%可信区间[CI] 0.54-1.56)和肺炎(风险比[HR] 1.01, 95%可信区间[CI] 0.83-1.24)两组间无显著差异。结论:内镜检查前使用GLP-1 RA不会增加呼吸并发症,支持术前继续用药。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Endoscopy International Open
Endoscopy International Open GASTROENTEROLOGY & HEPATOLOGY-
自引率
3.80%
发文量
270
期刊最新文献
Long-term outcomes of surveillance or endoscopic therapy for low-grade dysplastic Barrett's according to a selective management algorithm. Treatment of benign biliary strictures with expandable biodegradable stents: Safety and efficacy in a single center. Size, morphology, site, and access scoring variability as a barrier to standardization and automation. Reply to Koulaouzidis and Marlicz. Groove area involvement predicts post-ERCP pancreatitis after 8-mm fully-covered metal stent placement in resectable pancreatic cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1